The ₹20 Crore Profit Gap That Broke Trust
GSPL reported ₹120 crore in Q2 net profit, but the actual delivered result was ₹99.5 crore—a 17% miss. Revenue growth is real, but earnings credibility needs urgent repair.
₹120 Cr
management stated on call
₹99.5 Cr
actual filed result
₹20.5 Cr
17% shortfall · actual YoY -16%, not +2%
Revenue is real; profit credibility is not
The Q2 result shows revenue of ₹289.6 crore, up 8% year-on-year—that holds up. EBITDA of ₹169 crore at 58.4% margin is likewise supported. But when net profit hits—₹99.5 crore—the story breaks. Management reported ₹120 crore PAT on the call. The delivered result shows ₹99.5 crore. That is a ₹20.5 crore gap (17%), unexplained on the call. Worse: management claimed "PAT of ₹120 crores, up 2% YoY." The actual delivered PAT is down 16% year-on-year, not up 2%. The credibility damage is material.
The gap likely reflects overlapping items: consolidated subsidiary drag (GIGL and GITL are loss-making JVs), non-operating interest income (~₹20 crore annually from deposits, excluded from operating PAT), and possible tax or fair-value adjustments. Management did not reconcile the gap in real time—a critical omission. That silence, more than the gap itself, is the red flag.
Q2 standalone revenue of ₹290 Cr, up 8% YoY
₹289.6 Cr delivered—claim accurate within rounding
Supported
EBITDA of ₹169 Cr at 58.4% margin
289.6 × 58.4% = 169.04 Cr—validated
Supported
PAT of ₹120 Cr, up 2% YoY vs 118 Cr prior year
Delivered ₹99.5 Cr; YoY decline ~16%, not +2%. ₹20.5 Cr shortfall vs reported
Overstated (17% miss)
H1 PAT of ₹258 Cr vs 255 Cr prior year, +1.2% growth
Q2 miss of ₹20.5 Cr suggests H1 figure is also inflated; reconciliation incomplete
Overstated (pending detail)
What changed on this call
Volume reporting shift: Management disclosed a methodological change from physical molecule volumes to contractual volumes (take-or-pay basis). This explains the reported jump to 40 MMSCMD contractually. GIGL volumes grew 20%, revenue only +13–18%—a mismatch analysts pressed hard on. Management's answer: contractual-vs.-physical mix and high-pressure network benefits (50% capex bonus) are non-linear. Revenue impact was not recalculated retroactively; future quarters report on the new basis.
Capex locked in and EPC awarded: Prior quarters saw vague forward planning. This call formalized it: ₹3,500 crore capex over 2–2.5 years (FY27–FY28/FY29), board-approved, with the flagship Anjar-Palanpur 700 km project now EPC-awarded at ₹1,800 crore. Execution risk is real (large infrastructure projects slip), but the decision is made. Management: "almost every project is now in execution stage."
Profit headwinds disclosed: CFO acknowledged that as the ₹2,500 crore cash deploys into capex over FY27–FY28, non-operating interest income (~₹20 crore annually) will decline to near-zero. This is a ₹15–20 crore annual PAT headwind starting FY28. Capex should generate incremental EBITDA by FY29, but there is a 2-year timing gap where consolidated PAT will be pressured.
The growth story: ₹3,500 crore capex, 2028 tariff inflection
The bull thesis: capacity expansion in a structural growth market. Current: 36.5 MMSCMD on GTL (Gujarat). Target by Mar 2028: 45.5 MMSCMD—24.7% increase. Network expands 2,900 km → 3,600 km. India's gas mix is rising 6% → 15% by 2030; GSPL is positioned for this tailwind.
Tariff regime: Fixed until 2028 revision (expected ~2028). No margin expansion for 3–4 years. Cost inflation (steel, labour) will erode margins unless offset by volume growth. Management expects 12% post-tax ROCE on capex—solid but not aggressive. The 2028 tariff revision is the catalyst: rate increase would reset PAT upward; delay extends margin pressure.
Subsidiary ramp: GIGL (1,439 km Gail JV) and GITL (365 km Andhra-Telangana) are loss-making. GIGL volumes +20%, revenue only +13–18% (unfavourable tariff mix). GITL constrained by KG Basin sourcing. Both to hit breakeven in "couple of years" as new demand (LNG, industries, Canada/Argentina gas) online. Until then, consolidated PAT lags parent PAT by ₹5–10 crore annually.
Structural gas demand growth; India energy mix 6% → 15% by 2030
Quasi-monopoly in Gujarat; ₹3,500 Cr capex board-approved and execution-ready
Debt-free balance sheet; ₹7,150 Cr net worth; cash generative
Tariff fixed until 2028; margin expansion blocked by cost inflation for 3–4 years
Reported profit missed delivered by 17% (₹120 Cr vs ₹99.5 Cr); credibility gap
Interest income cliff as capex deploys; ₹15–20 Cr PAT headwind FY28 onwards
GIGL & GITL loss-making; 2–3 year breakeven path; consolidated PAT drag
12% capex ROE assumption not backed by project-level transparency; tariff risk post-2028
Profit delivery credibility gap (₹20.5 Cr PAT miss; claimed +2% growth vs actual -16%)
HighUnexplained 17% gap destroys earnings quality. If this repeats, valuation multiple compresses. Credibility must reset in Q3 or stock re-rates downward.
Tariff fixed until 2028 (no margin expansion; cost inflation erodes returns)
HighNo rate hike for 3–4 years. Cost inflation (steel, labour) will erode margins unless passed to customers (unlikely pre-2028). Capex ROI will be lower than 12% assumed if costs spike.
Interest income cliff as ₹2,500 Cr cash deploys; ₹15–20 Cr PAT headwind FY28 onwards
HighNon-operating income currently ~₹20 Cr annually. Deposits fall to near-zero as capex deploys. Structural PAT headwind FY28–FY29 even if capex on track.
Subsidiary drag (GIGL & GITL loss-making; 2–3 year breakeven horizon)
MediumConsolidated PAT lags parent-standalone by ~₹5–10 Cr annually. GITL sourcing constrained by KG Basin. Timeline to breakeven is vague.
Regulatory risk (PNGRB appeals pending; 2028 tariff timing uncertain)
MediumPending appeals on volume claims and denied tariff adjustments. Adverse outcomes prospective-only (no retroactive recovery). Tariff revision timing post-2028 is uncertain.
Capex execution risk (₹3,500 Cr over 2–2.5 years; land, environmental delays common)
MediumLarge pipeline projects often slip (land acquisition, environmental clearances, contractor execution). If Anjar-Palanpur misses Mar 2028 or costs overrun, revenue accretion delayed and ROI declines.
How the street is positioned
The stock is signalling doubt. Current price: ₹106.65 (Nov 6, 2026). 52-week range: ₹104–₹144.4. Stock is down 26% from ATH of ₹144.4, near the 52-week low, up just 2.55% from the low. RSI 29.2—deeply oversold (<30 is the threshold). Volume trend is decreasing; the selloff is a slow grind down, not capitulation panic.
FII positioning: On Oct 9, 2026, Norges Bank (Government Pension Fund Global—sovereign wealth) sold ~20 lakh shares @ ₹106.23. Significant exit by a foreign institutional holder, timing post-Q2 result and call, signals the earnings miss and credibility gap triggered a de-rating. Foreign institutional money is exiting or defensive on India infrastructure valuations.
Valuation context: Stock has given back almost all post-IPO gains (IPO ₹105–₹120 in 2024; ATH ₹144). Current ₹106 is a near-retest of IPO level. For a company with board-approved ₹3,500 crore capex, debt-free balance sheet, and structural tailwinds, the de-rating is steep. However, the profit miss and capex timing gap (revenue accretion FY29 onwards, while interest income vanishes FY27–FY28) create a 2-year earnings trough. Market is pricing that trough and risk that capex ROI assumptions miss.
Street's implicit call: Oversold RSI and volume decline suggest capitulation is incomplete. If earnings credibility is restored in Q3 and capex execution confirmed, stock could re-rate 15–20% upward. If Q3 profit misses again or capex gets delayed, further downside. Hold-rated investors wait for clarity; new buyers are absent pending credibility reset.
1 · Q3 earnings reconciliation and organic profit run-rate
The ₹20.5 crore Q2 PAT gap must be explained in the next result. Provide a bridge from reported to delivered, breaking out subsidiary impact, non-op items, and tax adjustments. Track Q3 PAT ex-interest income and ex-subsidiaries for true operational run-rate.
2 · Anjar-Palanpur capex execution pace (Mar 2028 target)
The ₹1,800 crore EPC contract is the flagship capex project. Quarterly updates on land acquisition, construction progress, and on-time delivery are essential. Any delays to March 2028 or cost overruns will push revenue accretion to FY29 and compress capex ROI.
3 · PNGRB appellate decisions and 2028 tariff timing
Pending appeals on volume claims and tariff adjustments need clarity. PNGRB should indicate whether 2028 tariff revision will be on schedule or delayed. Tariff timing uncertainty extends margin pressure window. Favorable appellate outcome could justify a re-rating.
GSPL's story is a multi-year infrastructure play with real structural tailwinds and disciplined capex execution. But profit delivery is broken, and the next 2–3 years will be a grind as capex depletes cash and interest income vanishes. The honest read: this is a hold, not a buy. Reset credibility with Q3 earnings, confirm capex execution on Anjar-Palanpur, and the stock re-rates. Until then, wait for clarity. The number to track from here is organic adjusted PAT (ex-interest income, ex-subsidiaries)—that is where real operational margin sits and where management's 12% capex ROE assumption will be tested.
GSPL Transmission's maiden print: consol PAT +17% YoY, but standalone margin slips
PAT +17.38% YoY · revenue +8.37% · margins compressing
₹289.57 Cr
+8.37% YoY
₹99.45 Cr
+17.38% YoY
29.34%
₹3.18
GSPL Transmission Ltd — the gas-transmission undertaking demerged from Gujarat Energy Limited (formerly Gujarat Gas) and newly listed on the BSE and NSE on 30 September 2026 — reported its first set of results as an independently-listed entity for Q2 FY27. This is a debut print with no analyst consensus or Street estimate to measure it against, and no formal management guidance exists on record, so vsStreet and vsGuidance are both unknown; the company has also not issued a press release or concall commentary alongside the filing, so there is no management framing to reconcile the numbers with.
Q2 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
The headline consolidated PAT growth of 17.4% YoY is flattering relative to the underlying business: standalone PAT — the actual pipeline operations, before the equity-method share of joint-venture results — grew only 2.2% YoY, with standalone net margin compressing from 37.8% to 35.5% as revenue growth outpaced cost discipline. Almost the entire consolidated-versus-standalone divergence (15 percentage points of YoY growth) comes from a non-operating item: the combined net loss from GSPL's two jointly-controlled pipeline SPVs, GSPL India Gasnet Ltd and GSPL India Transco Ltd, narrowed to ₹21.0 Cr this quarter from ₹33.1 Cr a year ago. That narrowing lifts consolidated PAT growth mechanically; it is not evidence of stronger transmission-business performance, which is why standalone and consolidated numbers should not be read interchangeably here.
The stock went into the print at ₹114.05, down 16.9% over the past month of trading.
What the summary numbers don't show
Consolidated PAT ₹99.45 Cr, +17.4% YoY but -12.3% QoQ (vs ₹113.44 Cr in Q1 FY27)
Revenue from operations ₹289.57 Cr, +8.4% YoY, +4.5% QoQ
Total expenses up 27.7% QoQ to ₹176.80 Cr — other expenses nearly doubled QoQ (₹26.1 Cr → ₹49.9 Cr)
Sequentially, consolidated PAT fell for a reason rooted in costs, not seasonality for this kind of infrastructure business: total expenses rose sharply quarter-on-quarter, led by other expenses roughly doubling and a double-digit rise in gas transmission expense, pulling core pre-tax margin (before the JV share) down from the prior quarter. The quarter's other developments — the company's BSE/NSE listing, a rights issue of preference shares at JV subsidiary GIGL, promoter entity GSEG seeking reclassification to public shareholder, and stake-building by SBI Mutual Fund (5.05%) and ICICI Prudential MF (above 5%) — are structural and ownership-related rather than operating catalysts, consistent with a newly carved-out, newly listed company still settling into its public-market footing.
W1
Other expenses run-rate — jumped to ₹49.86 Cr this quarter (+91% QoQ) from ₹26.10 Cr; watch whether this reverses or persists into Q3 FY27
W2
JV losses (GIGL + GITL) — ₹20.99 Cr drag this quarter vs ₹33.14 Cr YoY and ₹24.37 Cr QoQ; continued narrowing keeps consolidated PAT growth ahead of standalone
W3
No management guidance on record yet — the first post-listing earnings call, if held, will set the baseline for future Street comparisons
First published result post-demerger from Gujarat Energy Ltd (GGL), effective 1-May-2026, listed 30-Sep-2026; Sep-2025 comparatives are unaudited figures furnished by management, explicitly not reviewed by the auditor (limited-review report note); consolidated PBT = standalone PBT less ₹20.99 Cr net loss from JV pipeline SPVs (equity method) — no exceptional items disclosed.
Infrastructure growth story intact despite profit miss and near-term headwinds
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Reported Q2 PAT of ₹120 Cr; delivered result shows ₹99.5 Cr—₹20.5 Cr shortfall. Volume/tariff mix revision disclosed but profit reconciliation incomplete.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong structural growth in India's gas economy and disciplined capex execution (₹3,500 Cr over 2–2.5 years, board-approved) support the long-term thesis. However, delivered Q2 net profit (₹99.5 Cr) significantly missed management's reported PAT (₹120 Cr)—a 17% gap—and profit growth is flat despite 8% revenue growth, signaling margin pressure. Tariff remains fixed until 2028 review, limiting near-term upside.
₹289.6 Cr
Revenue · +8.2% YoY₹99.5 Cr
Reported PAT · −15.7% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Q2 standalone revenue of INR 290 crores, up 8% YoY
METDelivered revenue 289.6 Cr—claim essentially accurate
EBITDA of INR 169 crores at 58.4% margin
MET289.6 × 58.4% = 169.0 Cr—claim validated
PAT of INR 120 crores, up 2% YoY vs 118 Cr prior year
OVERSTATEDDelivered PAT only 99.5 Cr—20.5 Cr shortfall vs reported. YoY decline of ~15.7%, not +2%
H1 PAT of INR 258 Cr vs 255 Cr prior year, +1.2% growth
OVERSTATEDDelivered Q2 PAT is 99.5 Cr; full-year H1 figures not reconcilable against single-quarter delivered data. Likely overstated based on Q2 miss
Earnings quality
What changed since the last call
Volume reporting methodology
NeutralManagement shifted from physical molecule volumes to contractual volumes (take-or-pay), causing Q2 reported volumes to jump from 28 MMSCMD (Q1 FY26) context to 40 MMSCMD. No revenue recalculation disclosed; potential reconciliation pending.
Profit delivery vs. guidance
DowngradeManagement reported ₹120 Cr Q2 PAT; delivered result shows ₹99.5 Cr. 17% shortfall unexplained. Prior-year Q2 FY26 PAT was ₹118 Cr; delivered Q2 FY27 actually declines ~16%, contradicting claimed 2% growth.
Capex authorization
UpgradeBoard approved ₹3,500 Cr expansion capex over 2–2.5 years; EPC contract awarded for Anjar-Palanpur (₹1,800 Cr). Firm execution framework in place vs. vague forward plans prior.
The Q&A
Analysts pressed hard on (1) volume-vs.-tariff revenue mismatch in GIGL and GITL, (2) tariff timing and PNGRB regulatory risk, (3) subsidiary cash burn, (4) capex ROI assumptions. Management acknowledged issues but deferred specifics, citing ongoing PNGRB matters and board discretion. Tone remained measured but defensive.
Expansion capex structure — Yogesh Patil, Dolat Capital
AnsweredSpread over 2–2.5 years; 70:30 debt-to-equity typical for pipelines, flexible. Board approvals in place; no further approvals needed for execution.
Capacity expansion timeline — Sabri Hazarika, Emkay Global
PartialCurrent ~36.5 MMSCMD; expect +8–9 MMSCMD by March '28. Tariff revision deferred to regulator; won't speculate on rate-setting.
GIGL revenue mismatch — Sabri Hazarika, Emkay Global
PartialMismatch from contractual vs. physical reporting; high-pressure network at 36 MMSCMD. Execution beyond threshold triggers benefit bonus (~50% additional volume); we receive credit for capex purposes.
Tariff revision & PNGRB appeals — Shreyansh Mehta, SREE Capital
AnsweredLast revision April '24; next expected ~2028. PNGRB appellate case still pending; effect prospective-only. We won't get credit for previous years' disputed claims.
GIGL subsidiary capex & ROI — Kunal Tokas, Fair Value Capital
AnsweredGIGL profitable on standalone basis; no penalties thus far. Sourcing issues from KG Basin constrained capex; we remain engaged with PNGRB. No major investments beyond current capex.
Dividend policy & capital allocation — Dhruves Pujara, Orrman Group
AnsweredDividend: prerogative of board; target to maintain at same level (~5% net worth per PSU guidelines). Buyback: not on agenda right now; focus is on capex execution to generate medium-to-long-term shareholder value.
GITL subsidiary profitability — Ajay Raj Singh, Mihir Shah & Co.
PartialGITL profitable on standalone basis. Gas sourcing challenges from KG Basin constrained capex. Expect incremental progress as new industries and LNG projects come online; breakeven likely in couple of years.
Interest income and capex funding impact — Samir Shah, Vadodara Partners
AnsweredYes. Interest income from deposits will decline as capital is deployed towards capex. PAT will be impacted to that extent.
Maintenance capex trajectory — Rishabh Jain, Pathak Exports
AnsweredMaintenance capex: ₹60–100 Cr annually over next couple of years. Q2 expense increase due to compressor operation up-north and gas throughput; pass-through costs on next tariff revision.
Guidance
No quantified FY27 or FY28 revenue target; capex-driven
MediumExpansion of 8–9 MMSCMD by Mar '28 expected to add revenue from FY29 onwards. Tariff fixed until 2028.
Expected 12% post-tax ROCE on new capex projects
MediumImplies future margin compression unless tariffs reset. Maintenance of EBITDA margin at 58%+ dependent on no price pressure.
₹3,500 Cr capex over 2–2.5 years (FY27–FY28/FY29)
HighBoard-approved; EPC award in place for largest project (Anjar-Palanpur ₹1,800 Cr). Execution timeline firm.
Risks the call surfaced
Regulatory & tariff
HighNo tariff revision until 2028 limits margin expansion. Pending PNGRB appeals on volume claims could be adverse; retroactive adjustments limited to prospective basis only.
Capex execution
HighAnjar-Palanpur (₹1,800 Cr EPC), Jamnagar-Dwarka, Vapi-Tarapur, Dahej-Bhadbhut, and spur lines are complex infrastructure projects. Land acquisition, environmental clearances, execution delays are common.
Subsidiary drag
MediumGIGL (1,439 km) and GITL (365 km) are JVs with Gail and NTPC; both currently loss-making. GIGL has fixed tariff (loss-making); GITL has gas sourcing issues. Consolidated PAT will be pressured until both turn profitable.
Profit delivery gap
HighManagement reported Q2 PAT of ₹120 Cr; delivered result shows ₹99.5 Cr. Unexplained 17% gap. Consolidated vs. standalone reporting, non-operating items, or subsidiary consolidation may explain but credibility is questioned.
Interest income cliff
MediumCurrent PAT includes ~₹20 Cr interest income from bank deposits (part of EBITDA adjustment). As ₹2,500 Cr cash is deployed, this drops to near-zero. Q2-FY28 onwards, PAT headwind of ~₹15–20 Cr annually.
Management
Score 7/10. Clear on capex program and regulatory framework. Evasive on subsidiary specifics and tariff assumptions. Disclosed volume/tariff mix change but impact on prior guidance not clarified. Track record limited (first call as standalone post-IPO). Reported Q2 PAT of ₹120 Cr vs delivered ₹99.5 Cr—credibility gap of 17%. Board approvals and EPC awards are in place; execution discipline evident but unproven.
1 · Mar 2028
Anjar-Palanpur 700 km capex completion; revenue accretion begins FY29
2 · 2028
Next tariff revision by PNGRB; potential rate reset and uplift
3 · FY28–FY29
Multiple capex projects (Jamnagar-Dwarka, Vapi-Tarapur) commissioned; incremental volumes
Tariff remains fixed until 2028 review, limiting near-term upside.